On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Watch: Words Matter - How to Draft Arbitration Agreements That Hold Up in Court - Employment Law This Week
- One Nation, One Privacy Law: GOP Introduces Federal Privacy Legislation
- DOL Proposes New Safe Harbor for Selection of Designated Investment Alternatives for Defined Contribution Plans
- Watch: Joint Employment, Misclassification, I-9s, and Web Accessibility - New Rules and Rulings Reshape Employer Risk - Employment Law This Week
- Critical Infrastructure at Risk: Project Glasswing Urges Attention to AI-Driven Cyber-Risks